Fluocinolone acetonide
Effect of fluocinolone acetonide 0.2 μg/day implant on the decision to drive in patients with diabetic macular oedema: a report from the FAME study
... µg/day fluocinolone acetone implant (FAc; ILUVIEN, Alimera Sciences) and the associated improvements in best- corrected visual acuity (BCVA) and central subfield thickness (CST) demonstrated in the ...
6
Cost effectiveness of fluocinolone acetonide implant (ILUVIEN®) in UK patients with chronic diabetic macular oedema considered insufficiently responsive to available therapies
... A number of drugs used to treat DMO are available to UK patients on the National Health Service (NHS), following a positive recommendation from the National Institute for Health and Care Excellence (NICE). These include ...
14
Surgical management of fibrotic encapsulation of the fluocinolone acetonide implant in <em>CAPN5</em>-associated proliferative vitreoretinopathy
... the dimensions of the fluocinolone acetonide implant. The dotted red lines indicate the placement and orientation of incisions created in the surrounding fibrotic capsule with a microvitreoretinal (MVR) ...
6
Fluocinolone acetonide intravitreal sustained release device – a new addition to the armamentarium of uveitic management
... The Fluocinolone Acetonide Uveitis Study Group will con- tinue following the study patients in their multi-centered trial for an additional year, with fi nal results of the study to be published at that ...
10
Injectable 0.19-mg fluocinolone acetonide intravitreal implant for the treatment of non-infectious uveitic macular edema
... So far, the injectable FAc implant is only indicated for the treatment of DME. The FAME trials investigated the safety and efficacy of the FAc implant [12]. This was a multicenter clinical trial involving 375 DME ...
9
The efficacy and safety outcomes of the 0.19 mg fluocinolone acetonide implant after prior treatment with the 0.7 mg dexamethasone implant in patients with diabetic macular edema
... (fluocinolone acetonide [FAc]) implant received its first European medicinal license approval in 2012 and is therefore a relatively recent development for the treatment of DME, where it is indicated for the ...
5
STABILITY INDICATING RP-HPLC METHOD DEVELOPMENT AND VALIDATION OF SIMULTANEOUS ESTIMATION OF CIPROFLOXACIN AND FLUOCINOLONE ACETONIDE IN BULK AND PHARMACEUTICAL DOSAGE FORM
... repair, and recombination. Ciprofloxacin is an antibiotic used to treat a number of bacterial infections. This includes bone and joint infections, intra-abdominal infections, certain type of infectious diarrhea, ...
14
Clinical utility of intravitreal fluocinolone acetonide (Iluvien<sup>®</sup>) implant in the management of patients with chronic diabetic macular edema: a review of the current literature
... The fluocinolone acetonide (FA) 190 μg intravitreal implant has been shown in pivotal clinical trials to be efficacious for the treatment of DME and has been approved in many countries for use in patients ...
8
Long-term follow-up of patients treated with multiple fluocinolone acetonide implants for noninfectious uveitis
... a fluocinolone acetonide implant and at least 1 month of follow-up after the second implant was ...a fluocinolone aceto- nide implant, eight eyes of eight patients had exchange of the implant and met ...
6
Fluocinolone acetonide and its potential in the treatment of chronic diabetic macular edema
... of fluocinolone acetonide after 12 months were the primary endpoint and change in visual acuity compared with baseline at 12 months was the secondary ...
7
Treating Diabetic Macular Oedema (DMO): real world UK clinical outcomes for the 0.19mg Fluocinolone Acetonide intravitreal implant (Iluvien™) at 2 years
... Fluocinolone acetonide [FAc] ...the Fluocinolone Acetonide in Diabetic Macular Edema (FAME) A and B randomized clinical trials which showed clinical effect- iveness of 36 months duration [11, ...
7
<p>Effectiveness of 190 μg Fluocinolone Acetonide and 700 μg Dexamethasone Intravitreal Implants in Diabetic Macular Edema Using the Area-Under-the-Curve Method: The CONSTANT Analysis</p>
... uocinolone acetonide (total dose of ...(Fluocinolone Acetonide for Macular Edema) and MEAD pivotal clinical trials in diabetic macular edema ...
8
Ahmed glaucoma valve in uveitic patients with fluocinolone acetonide implant-induced glaucoma: 3-year follow-up
... Results: Nine patients with 10 uveitic eyes were included in this study, none of which had preexisting glaucoma in the study eye. Mean patient age was 42 years; 6 patients were female and 3 were male. Baseline mean IOP ...
6
Fluocinolone acetonide intravitreal implant for the treatment of diabetic macular edema
... The fluocinolone acetonide devices are one of the latest therapies considered for the treatment of ...acuity, fluocinolone devices are associated with cataract formation, increased intraocular ...
10
A novel intravitreal fluocinolone acetonide implant (Iluvien<sup>®</sup>) in the treatment of patients with chronic diabetic macular edema that is insufficiently responsive to other medical treatment options: a case series
... (Fluocinolone Acetonide in patients with diabetic Macular Edema) studies they evaluated 953 eyes of patients with persistent DME after one or more laser therapy treatments, randomized 1:2:2 for sham ...
11
Efficacy and safety of sustained-delivery fluocinolone acetonide intravitreal implant in patients with chronic diabetic macular edema insufficiently responsive to available therapies: a real-life study
... Two groups were defined in advance: group 1 included patients having received previous treatment in the study eye with laser photocoagulation for DME at least 3 months prior to the sc[r] ...
8
<p>Early adoption of the fluocinolone acetonide (FAc) intravitreal implant in patients with persistent or recurrent diabetic macular edema (DME)</p>
... Improvements in macular volume were also statistically signi fi cant, irrespective of whether eyes had received one to three or four to six previous treat- ments, and improvements in reti[r] ...
10
Post-cataract outcomes in patients with noninfectious posterior uveitis treated with the fluocinolone acetonide intravitreal implant
... Purpose: To describe visual acuity (VA) and inflammation following cataract surgery in eyes with noninfectious posterior uveitis (NIPU) that were being treated with a fluocinolone acet[r] ...
7
DEVELOPMENT AND EVALUATION OF FLUOCINOLONE ACETONIDE AND NEOMYCIN SULPHATE NANOMIEMGEL FOR TOPICAL DRUG DELIVERY SYSTEM
... Topical delivery involves drug transport at the skin surface or transport to the dermal layer of skin for localized drug action, whereby transdermal delivery is the delivery of drug acro[r] ...
15
<p>Real-world retrospective comparison of 0.19 mg fluocinolone acetonide and 0.7 mg dexamethasone intravitreal implants for the treatment of diabetic macular edema in vitrectomized eyes</p>
... In the DEX-treated eyes that completed 6 months ’ follow-up, CFT decreased by approximately 133.1 µm at month 1, which is more than what was reported in similar real-world studies such a[r] ...
9